Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO
CEO of TRHC’s New Research & Development Institute to Present at National University of Singapore
25 févr. 2019 08h00 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that...
Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO
Tabula Rasa HealthCare Announces Launch and Location of New Scientific Precision Pharmacotherapy Research & Development Institute
21 févr. 2019 10h33 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J. and ORLANDO, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety,...